Market closedNon-fractional

Certara/CERT

13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1YMAX

About Certara

Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.

Ticker

CERT

Sector

Healthcare

Trading on

NASDAQ

Industry

Health Care Technology

Headquarters

Princeton, United States

Employees

1,365

Certara Metrics

BasicAdvanced
$2.2B
Market cap
-
P/E ratio
-$0.39
EPS
1.58
Beta
-
Dividend rate
$2.2B
1.58
3.264
3.038
28.397
29.094
1.33%
1.24%
-5.74%
6.03
2.07
-16.2
35.71
4.73%
-541.65%
12.58%
2.58%

What the Analysts think about Certara

Analyst Ratings

Majority rating from 11 analysts.
Hold

Certara Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-4.76% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$97M
9.77%
Net income
-$4.6M
-62.90%
Profit margin
-4.76%
-66.22%

Certara Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 1.01%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.12
$0.11
$0.09
$0.10
-
Expected
$0.13
$0.11
$0.11
$0.10
$0.10
Surprise
-4.55%
0.92%
-17.43%
1.01%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Certara stock?

Certara (CERT) has a market cap of $2.2B as of July 04, 2024.

What is the P/E ratio for Certara stock?

The price to earnings (P/E) ratio for Certara (CERT) stock is 0 as of July 04, 2024.

Does Certara stock pay dividends?

No, Certara (CERT) stock does not pay dividends to its shareholders as of July 04, 2024.

When is the next Certara dividend payment date?

Certara (CERT) stock does not pay dividends to its shareholders.

What is the beta indicator for Certara?

Certara (CERT) has a beta rating of 1.58. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell Certara stock

Buy or sell Certara stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing